The store will not work correctly when cookies are disabled.
2-(4-Ethyl-6,6-dimethyl-2-oxomorpholin-3-yl)-N-(1-methyl-1H-indol-5-yl)acetamide
ID: ALA3407673
PubChem CID: 53244722
Max Phase: Preclinical
Molecular Formula: C19H25N3O3
Molecular Weight: 343.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CC(C)(C)OC(=O)C1CC(=O)Nc1ccc2c(ccn2C)c1
Standard InChI: InChI=1S/C19H25N3O3/c1-5-22-12-19(2,3)25-18(24)16(22)11-17(23)20-14-6-7-15-13(10-14)8-9-21(15)4/h6-10,16H,5,11-12H2,1-4H3,(H,20,23)
Standard InChI Key: ZPVVOKSYONOZRG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
-3.8968 8.8166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9480 8.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0030 8.8097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6465 7.4922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2445 7.4835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.2396 5.9835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9380 5.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6415 5.9922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.2768 5.3801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.9300 3.7369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6187 1.4919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5905 3.5979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3377 5.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3013 5.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 2 1 0
4 8 1 0
2 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
6 9 2 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
8 14 1 0
14 15 1 0
12 16 1 0
16 17 2 0
17 18 1 0
18 21 2 0
20 19 2 0
19 16 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 20 1 0
22 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.43 | Molecular Weight (Monoisotopic): 343.1896 | AlogP: 2.53 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.57 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.86 | CX Basic pKa: 6.10 | CX LogP: 2.38 | CX LogD: 2.36 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.87 | Np Likeness Score: -0.72 |
References
1. Bardiot D, Thevissen K, De Brucker K, Peeters A, Cos P, Taborda CP, McNaughton M, Maes L, Chaltin P, Cammue BP, Marchand A.. (2015) 2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents., 58 (3): [PMID:25585716] [10.1021/jm501814x] |